JP2022543826A5 - - Google Patents
Info
- Publication number
- JP2022543826A5 JP2022543826A5 JP2022507487A JP2022507487A JP2022543826A5 JP 2022543826 A5 JP2022543826 A5 JP 2022543826A5 JP 2022507487 A JP2022507487 A JP 2022507487A JP 2022507487 A JP2022507487 A JP 2022507487A JP 2022543826 A5 JP2022543826 A5 JP 2022543826A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- chem
- integer
- range
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19190571 | 2019-08-07 | ||
| EP19190571.0 | 2019-08-07 | ||
| PCT/EP2020/072137 WO2021023817A1 (en) | 2019-08-07 | 2020-08-06 | Solid composition comprising a pyy compound and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022543826A JP2022543826A (ja) | 2022-10-14 |
| JP2022543826A5 true JP2022543826A5 (https=) | 2023-07-31 |
Family
ID=67587403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022507487A Withdrawn JP2022543826A (ja) | 2019-08-07 | 2020-08-06 | Ｐｙｙ化合物とｎ－（８－（２－ヒドロキシベンゾイル）アミノ）カプリル酸の塩とを含む固形組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220280611A1 (https=) |
| EP (1) | EP4009957B1 (https=) |
| JP (1) | JP2022543826A (https=) |
| CN (1) | CN114206375A (https=) |
| ES (1) | ES2969534T3 (https=) |
| WO (1) | WO2021023817A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023084118A1 (en) | 2021-11-15 | 2023-05-19 | Adocia | Solid compositions comprising a peptide or a protein and an acylated amino acid |
| EP4299057A1 (en) | 2022-06-30 | 2024-01-03 | Adocia | Solid compositions comprising a peptide or a protein and an acylated amino acid |
| EP4180060A1 (en) | 2021-11-15 | 2023-05-17 | Adocia | Solid compositions comprising a peptide or a protein and an acylated amino acid |
| EP4299052A1 (en) | 2022-06-30 | 2024-01-03 | Adocia | Solid compositions comprising a peptide or a protein and a permeation enhancer |
| EP4299071A1 (en) | 2022-07-01 | 2024-01-03 | Adocia | Compositions comprising a peptide or a protein and an acylated amino acid |
| JP2025526148A (ja) * | 2022-08-18 | 2025-08-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 長時間作用型ｇｌｐ－１／グルカゴン受容体アゴニスト及びｎｐｙ２受容体アゴニストを含む組合せ治療 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0411165A (pt) * | 2003-05-14 | 2006-07-11 | Emisphere Tech Inc | composição farmacêutica, forma de unidade de dosagem e métodos para preparar seu uso |
| GB0504857D0 (en) * | 2005-03-09 | 2005-04-13 | Imp College Innovations Ltd | Novel compounds and their effects on feeding behaviour |
| SI2651398T1 (en) * | 2010-12-16 | 2018-04-30 | Novo Nordisk A/S | SOLID COMPOSITIONS CONTAINING GLP-1 AGONIST AND SOL N- (8- (2-HYDROXYBENZOIL) AMINO) CAPRICULATE ACIDS |
| HRP20181447T1 (hr) * | 2012-03-22 | 2018-11-02 | Novo Nordisk A/S | Pripravci glp-1 peptida i njihova priprava |
| EP3068795B1 (en) * | 2013-11-15 | 2019-03-06 | Novo Nordisk A/S | Hpyy(1-36) having a beta-homoarginine substitution at position 35 |
| CN105722526B (zh) * | 2013-11-15 | 2020-12-08 | 诺和诺德股份有限公司 | 选择性pyy化合物及其用途 |
| WO2016124687A1 (en) * | 2015-02-04 | 2016-08-11 | Novo Nordisk A/S | Selective pyy compounds and uses thereof |
| TWI694082B (zh) * | 2015-06-12 | 2020-05-21 | 丹麥商諾佛 儂迪克股份有限公司 | 選擇性ｐｙｙ化合物及其用途 |
-
2020
- 2020-08-06 WO PCT/EP2020/072137 patent/WO2021023817A1/en not_active Ceased
- 2020-08-06 US US17/633,047 patent/US20220280611A1/en not_active Abandoned
- 2020-08-06 JP JP2022507487A patent/JP2022543826A/ja not_active Withdrawn
- 2020-08-06 CN CN202080055637.4A patent/CN114206375A/zh not_active Withdrawn
- 2020-08-06 EP EP20754702.7A patent/EP4009957B1/en active Active
- 2020-08-06 ES ES20754702T patent/ES2969534T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543826A5 (https=) | ||
| RU2470016C2 (ru) | Производное бипиразола | |
| JP2005530732A5 (https=) | ||
| US20090163408A1 (en) | Salicylanilides enhance oral delivery of therapeutic peptides | |
| JP6547034B2 (ja) | ペプチドの使用 | |
| RU2012128547A (ru) | Дважды ацилированные производные glp-1 | |
| MX355361B (es) | Derivados de peptido 1 tipo glucagon (glp-1) doblemente acilados. | |
| JP2010512753A5 (https=) | ||
| JP2010535714A (ja) | 長期間作用性ペプチド類似体のための組成物 | |
| JP2010515686A5 (https=) | ||
| CA2573512A1 (en) | Compositions for delivering peptide yy and pyy agonists | |
| CN101203531A (zh) | 修饰的pyy（3-36）多肽及它们对进食行为的影响 | |
| CA2729938A1 (en) | New insulin analogues of prolonged activity | |
| US20180280480A1 (en) | Compositions and peptides having dual glp-1r and glp-2r agonist activity | |
| RU2009110452A (ru) | Галеновые составы алискирена | |
| WO2020039051A1 (en) | Acylated calcitonin mimetics | |
| JP2006528152A5 (https=) | ||
| JP2004521123A5 (https=) | ||
| AU2022222674A1 (en) | Glucagon-like peptide-1 receptor antagonists | |
| EP1945243B1 (en) | Use of calcitonin for the treatment of ra | |
| JP7279061B2 (ja) | グルカゴン様ペプチド | |
| JP2025166052A (ja) | 肥満の治療における使用のためのｉｌ－４由来ペプチド | |
| WO2018211111A1 (en) | Dual amylin and calcitonin receptor agonists for treating diseases and disorders | |
| WO2014023923A2 (fr) | Traitement de l'arthrose par les hormones incrétines ou leurs analogues | |
| CN107847452A (zh) | 应答选择性C5a激动剂EP67的构象稳定类似物 |